Half trillion dollar PBM sector continues to grow

In the fragmented and complex US healthcare system, the market
value of pharmacy benefit managers (PBM) has reached new heights.

PBMs help administer drug insurance benefits in a variety of
ways, including by negotiating prices with manufacturers and
pharmacies, establishing formularies and processing claims.

Looking into the sector and its development, USA-based analyst
Research and Markets says the market for PBMs is now worth around
$491 billion.

…

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

• All the news that moves the needle in pharma and biotech.
• Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
• Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

• Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
• Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
• Daily roundup of key events in pharma and biotech.
• Monthly in-depth briefings on Boardroom appointments and M&A news.
• Choose from a cost-effective annual package or a flexible monthly subscription.